Asia
Shenzhen Edge Medical Plans HK$200 Million Share Buyback
Shenzhen Edge Medical (HKG:2675) plans to repurchase up to HK$200 million of its shares in the open market under an existing shareholder mandate, according to a Tuesday Hong Kong bourse filing.The company said repurchases will be conducted from time to time, subject to market conditions.The buyback authorization may cover up to 10% of the H-shares in issue at the time of the company's Hong Kong listing.The program will remain in effect until the earlier of the company's next annual general meeting or any shareholder-approved revocation or amendment of the mandate.
HKG:2675
